FAYETTEVILLE, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — January is traditionally a peak period for ...

Antifibrotic therapy shows similar efficacy in familial and sporadic IPF, with no significant differences in survival or acute exacerbations. Because familial idiopathic pulmonary fibrosis is ...

Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2 ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Older adults discharged from hospitals on multiple medications are less likely to regain independence during rehabilitation, a new study suggests. The Japanese study, published in the journal BMC ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

FAYETTEVILLE, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...

Dec. 19 (UPI) --President Donald Trump on Friday announced that nine of the largest drugmakers in the United States and Europe have agreed to voluntarily sell their medications at lower prices in a ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

The JAMP Pharma Group, a leader in the Canadian pharmaceutical industry, announces the launch of PrJAMP Nintedanib ...